Cytokinetics, Inc. (CYTK): Phase 3 trials are a virtual certainty....

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	53
Posts	4314
Boards Moderated	0
Alias Born	02/28/2010

Solantey

Re: FairviewInvestor post# 1170

Wednesday, 04/30/2014 9:16:13 AM

Wednesday, April 30, 2014 9:16:13 AM

Phase 3 trials are a virtual certainty.

Buy shares today.

Expecting $6.00-$7.00 by next Tuesday's conference call. Could be $8.00-$10.00 on Wednesday.

All IMHO.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CYTK News

Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 09:22:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:17:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:13:24 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 08:24:15 PM
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/11/2024 09:16:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:22:59 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 09:08:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:15:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:13:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:03:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:23:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 02:02:17 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:30:38 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:24:59 PM
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 09:07:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:36:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:33:48 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:25:01 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:20:58 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/03/2024 08:01:38 PM
Cytokinetics to Participate in June Investor Conferences • GlobeNewswire Inc. • 05/29/2024 08:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:01:04 PM
Cytokinetics Announces Closing of Public Offering of Common Stock • GlobeNewswire Inc. • 05/28/2024 08:00:00 PM

More CYTK News

InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover